Eltrombopag

Eltrombopag belongs to a class of drugs called thrombopoietin (TPO) receptor agonists, and is used to treat patients who have low platelet counts as a result of chronic immune thrombocytopenia or chronic hepatitis C virus infection. Eltrombopag is also used in combination with other drugs to treat conditions such as severe aplastic anemia. Generally, this medicine is administered to those patients who have not responded very well to other medicines, or surgery.

Eltrombopag is administered in the form of oral tablets, or via suspension, both of which are taken by the mouth, according to the dosage prescribed by the doctor.

Before using Eltrombopag, tell your doctor if you are using any prescription drugs, non-prescription drugs, or other herbal and dietary pills and supplements, if you are allergic to certain food items or substances, if you have a history of blood clots or blood related problems, or if you have a history of liver diseases.

Side effects of Eltrombopag include nausea, tiredness, fever, cough, headache, diarrhea, loss of appetite, flu and anemia.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

• Nausea

• Running Nose

• Back Pain

• Rash

• Mouth Ulcers

• Musculoskeletal Bone

• Muscle Or Joint Pain

• Oropharyngeal Pain

• Fever

• Upper Respiratory Tract Infection

• Nasopharyngitis

• Paresthesia (Tingling Or Pricking Sensation)

• Hair Loss

• Dry Eyes

• Cough

• Toothache

• Increased Liver Enzymes

• Menorrhagia

• Diarrhoea

• Muscle Cramps

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Revolade 50mg tablet may be unsafe to use during pregnancy.
  Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• Are there any breast-feeding warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

• Are there any missed dose instructions?

  If you miss a dose of Eltrombopag, skip it and continue with your normal schedule. Do not double the dose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

Below is the list of medicines, which contains Eltrombopag as ingredient

• Revolade 50Mg Tablet

  Glaxo SmithKline Pharmaceuticals Ltd

• Revolade 25mg Tablet

  Glaxo SmithKline Pharmaceuticals Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

This medication was developed in a bid to treat some conditions, which lead to thrombocytopenia. It acts by enhancing the c-mpl receptor. The primary target of this medicine is thrombopoietin.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.